Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • April 28, 2017

    Atty Deception Kills Pharma Whistleblower Suit, Judge Rules

    A Massachusetts federal judge on Friday sanctioned a whistleblower’s attorneys for misconduct in a suit alleging false claims to Medicare by tossing the case, ruling that the complaint wouldn’t have survived the dismissal phase had it not relied on unethically sourced evidence.

  • April 28, 2017

    10th Circ. Backs Law School Lecture Penalty For Okla. Atty

    The Tenth Circuit on Friday affirmed an Oklahoma federal judge’s decision ordering a lawyer to give lectures at the University of Tulsa law school, finding that the lower court had properly found that he mishandled a lawsuit over unwanted sales calls he claimed came from a supplement company.

  • April 28, 2017

    Warning Would Have Kept Woman From J&J Talc, Jury Told

    A woman who alleges her daily use of Johnson & Johnson’s talcum powder products over decades caused her to develop ovarian tumors testified for a Missouri jury on Friday, saying she wouldn’t have used the company’s products had they included any warnings about cancer risks.

  • April 28, 2017

    11th Circ. Backs Georgia 'Pill Mill' Doc's 20-Year Sentence

    The Eleventh Circuit on Thursday upheld a 20-year sentence for a doctor charged with 92 federal counts arising from his participation in two Georgia pain management clinics that purportedly operated as “pill mills,” saying he failed to prove error in the trial court's handling of the case.

  • April 28, 2017

    Retrophin Waived Privilege Over Atty Docs, Shkreli Says

    Retrophin Inc.’s cooperation with the government in the criminal case against Martin Shkreli and the company’s separate action against its former CEO amounts to a “wholesale waiver” of privilege over communications key to Shkreli’s defense, his attorneys told a New York federal court.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals